<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-20" modified="2020-10-07" version="173">
<accession>Q6P1J9</accession>
<accession>A6NLZ8</accession>
<accession>B2RBR2</accession>
<accession>Q6PK51</accession>
<accession>Q96A07</accession>
<accession>Q9H245</accession>
<accession>Q9H5L7</accession>
<name>CDC73_HUMAN</name>
<protein>
<recommendedName>
<fullName>Parafibromin</fullName>
</recommendedName>
<alternativeName>
<fullName>Cell division cycle protein 73 homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>Hyperparathyroidism 2 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDC73</name>
<name type="synonym">C1orf28</name>
<name type="synonym">HRPT2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Genomics" volume="73" first="211" last="222">
<title>Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus.</title>
<authorList>
<person name="Sood R."/>
<person name="Bonner T.I."/>
<person name="Malakowska I."/>
<person name="Stephan D.A."/>
<person name="Robbins C.M."/>
<person name="Connors T.D."/>
<person name="Morgenbesser S.D."/>
<person name="Su K."/>
<person name="Faruque M.U."/>
<person name="Pinkett H."/>
<person name="Graham C."/>
<person name="Baxevanis A.D."/>
<person name="Klinger K.W."/>
<person name="Landes G.M."/>
<person name="Trent J.M."/>
<person name="Carpten J.D."/>
</authorList>
<dbReference type="PubMed" id="11318611"/>
<dbReference type="DOI" id="10.1006/geno.2001.6500"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2008-02" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
<person name="Ramsay A."/>
<person name="Leung H.Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-9; 38-47; 78-87; 111-120; 127-136; 172-181; 212-222; 235-243; 248-257; 332-342; 379-385 AND 400-407</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Embryonic kidney</tissue>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="612" last="620">
<title>The parafibromin tumor suppressor protein is part of a human Paf1 complex.</title>
<authorList>
<person name="Rozenblatt-Rosen O."/>
<person name="Hughes C.M."/>
<person name="Nannepaga S.J."/>
<person name="Shanmugam K.S."/>
<person name="Copeland T.D."/>
<person name="Guszczynski T."/>
<person name="Resau J.H."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="15632063"/>
<dbReference type="DOI" id="10.1128/mcb.25.2.612-620.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PAF1; LEO1 AND POLR2A</scope>
<scope>INTERACTION WITH SET1-LIKE COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT HRPT1 PRO-64</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="5052" last="5060">
<title>The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.</title>
<authorList>
<person name="Yart A."/>
<person name="Gstaiger M."/>
<person name="Wirbelauer C."/>
<person name="Pecnik M."/>
<person name="Anastasiou D."/>
<person name="Hess D."/>
<person name="Krek W."/>
</authorList>
<dbReference type="PubMed" id="15923622"/>
<dbReference type="DOI" id="10.1128/mcb.25.12.5052-5060.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PAF1 AND POLR2A</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="1272" last="1276">
<title>Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.</title>
<authorList>
<person name="Woodard G.E."/>
<person name="Lin L."/>
<person name="Zhang J.-H."/>
<person name="Agarwal S.K."/>
<person name="Marx S.J."/>
<person name="Simonds W.F."/>
</authorList>
<dbReference type="PubMed" id="15580289"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208274"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="6241" last="6248">
<title>Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.</title>
<authorList>
<person name="Hahn M.A."/>
<person name="Marsh D.J."/>
</authorList>
<dbReference type="PubMed" id="16116486"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208778"/>
</citation>
<scope>CHARACTERIZATION OF NUCLEAR LOCALIZATION SIGNAL</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Nat. Genet." volume="32" first="676" last="680">
<title>HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.</title>
<authorList>
<person name="Carpten J.D."/>
<person name="Robbins C.M."/>
<person name="Villablanca A."/>
<person name="Forsberg L."/>
<person name="Presciuttini S."/>
<person name="Bailey-Wilson J."/>
<person name="Simonds W.F."/>
<person name="Gillanders E.M."/>
<person name="Kennedy A.M."/>
<person name="Chen J.D."/>
<person name="Agarwal S.K."/>
<person name="Sood R."/>
<person name="Jones M.P."/>
<person name="Moses T.Y."/>
<person name="Haven C."/>
<person name="Petillo D."/>
<person name="Leotlela P.D."/>
<person name="Harding B."/>
<person name="Cameron D."/>
<person name="Pannett A.A."/>
<person name="Hoeoeg A."/>
<person name="Heath H. III"/>
<person name="James-Newton L.A."/>
<person name="Robinson B."/>
<person name="Zarbo R.J."/>
<person name="Cavaco B.M."/>
<person name="Wassif W."/>
<person name="Perrier N.D."/>
<person name="Rosen I.B."/>
<person name="Kristoffersson U."/>
<person name="Turnpenny P.D."/>
<person name="Farnebo L.-O."/>
<person name="Besser G.M."/>
<person name="Jackson C.E."/>
<person name="Morreau H."/>
<person name="Trent J.M."/>
<person name="Thakker R.V."/>
<person name="Marx S.J."/>
<person name="Teh B.T."/>
<person name="Larsson C."/>
<person name="Hobbs M.R."/>
</authorList>
<dbReference type="PubMed" id="12434154"/>
<dbReference type="DOI" id="10.1038/ng1048"/>
</citation>
<scope>INVOLVEMENT IN HRPT2</scope>
<scope>INVOLVEMENT IN HRPT1</scope>
<scope>VARIANT HRPT1 PRO-64</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="N. Engl. J. Med." volume="349" first="1722" last="1729">
<title>Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.</title>
<authorList>
<person name="Shattuck T.M."/>
<person name="Vaelimaeki S."/>
<person name="Obara T."/>
<person name="Gaz R.D."/>
<person name="Clark O.H."/>
<person name="Shoback D."/>
<person name="Wierman M.E."/>
<person name="Tojo K."/>
<person name="Robbins C.M."/>
<person name="Carpten J.D."/>
<person name="Farnebo L.-O."/>
<person name="Larsson C."/>
<person name="Arnold A."/>
</authorList>
<dbReference type="PubMed" id="14585940"/>
<dbReference type="DOI" id="10.1056/nejmoa031237"/>
</citation>
<scope>INVOLVEMENT IN PRTC</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="350" first="17" last="24">
<title>Parafibromin inhibits cancer cell growth and causes G1 phase arrest.</title>
<authorList>
<person name="Zhang C."/>
<person name="Kong D."/>
<person name="Tan M.H."/>
<person name="Pappas D.L. Jr."/>
<person name="Wang P.F."/>
<person name="Chen J."/>
<person name="Farber L."/>
<person name="Zhang N."/>
<person name="Koo H.M."/>
<person name="Weinreich M."/>
<person name="Williams B.O."/>
<person name="Teh B.T."/>
</authorList>
<dbReference type="PubMed" id="16989776"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.08.169"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="125" first="327" last="341">
<title>Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.</title>
<authorList>
<person name="Mosimann C."/>
<person name="Hausmann G."/>
<person name="Basler K."/>
</authorList>
<dbReference type="PubMed" id="16630820"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.01.053"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CTNNB1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Mech. Dev." volume="124" first="59" last="67">
<title>BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.</title>
<authorList>
<person name="Hoffmans R."/>
<person name="Basler K."/>
</authorList>
<dbReference type="PubMed" id="17113272"/>
<dbReference type="DOI" id="10.1016/j.mod.2006.09.006"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH BCL9L; CTNNB1 AND PYGO1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="2765" last="2777">
<title>DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation.</title>
<authorList>
<person name="Chen Y."/>
<person name="Yamaguchi Y."/>
<person name="Tsugeno Y."/>
<person name="Yamamoto J."/>
<person name="Yamada T."/>
<person name="Nakamura M."/>
<person name="Hisatake K."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="19952111"/>
<dbReference type="DOI" id="10.1101/gad.1834709"/>
</citation>
<scope>IDENTIFICATION IN THE PAF1 COMPLEX</scope>
<scope>FUNCTION OF THE PAF1 COMPLEX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="755" last="760">
<title>The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors.</title>
<authorList>
<person name="Rozenblatt-Rosen O."/>
<person name="Nagaike T."/>
<person name="Francis J.M."/>
<person name="Kaneko S."/>
<person name="Glatt K.A."/>
<person name="Hughes C.M."/>
<person name="LaFramboise T."/>
<person name="Manley J.L."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="19136632"/>
<dbReference type="DOI" id="10.1073/pnas.0812023106"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CPSF1; CPSF4 AND CSTF2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Cancer Cell" volume="17" first="609" last="621">
<title>The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.</title>
<authorList>
<person name="Muntean A.G."/>
<person name="Tan J."/>
<person name="Sitwala K."/>
<person name="Huang Y."/>
<person name="Bronstein J."/>
<person name="Connelly J.A."/>
<person name="Basrur V."/>
<person name="Elenitoba-Johnson K.S."/>
<person name="Hess J.L."/>
</authorList>
<dbReference type="PubMed" id="20541477"/>
<dbReference type="DOI" id="10.1016/j.ccr.2010.04.012"/>
</citation>
<scope>FUNCTION OF THE PAF1 COMPLEX</scope>
<scope>INTERACTION WITH KMT2A</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Cell" volume="140" first="491" last="503">
<title>The human PAF1 complex acts in chromatin transcription elongation both independently and cooperatively with SII/TFIIS.</title>
<authorList>
<person name="Kim J."/>
<person name="Guermah M."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="20178742"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.12.050"/>
</citation>
<scope>IDENTIFICATION IN THE PAF1 COMPLEX</scope>
<scope>COMPOSITION OF THE PAF1 COMPLEX</scope>
<scope>FUNCTION OF THE PAF1 COMPLEX</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Mol. Cell" volume="41" first="409" last="418">
<title>Transcriptional activators enhance polyadenylation of mRNA precursors.</title>
<authorList>
<person name="Nagaike T."/>
<person name="Logan C."/>
<person name="Hotta I."/>
<person name="Rozenblatt-Rosen O."/>
<person name="Meyerson M."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="21329879"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.01.022"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION OF THE PAF1 COMPLEX</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2016" name="Biochem. Biophys. Res. Commun." volume="469" first="1133" last="1139">
<title>Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling.</title>
<authorList>
<person name="Noda S."/>
<person name="Takahashi A."/>
<person name="Hayashi T."/>
<person name="Tanuma S."/>
<person name="Hatakeyama M."/>
</authorList>
<dbReference type="PubMed" id="26742426"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2015.12.117"/>
</citation>
<scope>INTERACTION WITH PTPN11</scope>
<scope>DEPHOSPHORYLATION BY PTPN11</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-198; LYS-301; LYS-308 AND LYS-321</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2018" name="Cell" volume="175" first="1931" last="1945">
<title>Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.</title>
<authorList>
<person name="Shah P.S."/>
<person name="Link N."/>
<person name="Jang G.M."/>
<person name="Sharp P.P."/>
<person name="Zhu T."/>
<person name="Swaney D.L."/>
<person name="Johnson J.R."/>
<person name="Von Dollen J."/>
<person name="Ramage H.R."/>
<person name="Satkamp L."/>
<person name="Newton B."/>
<person name="Huettenhain R."/>
<person name="Petit M.J."/>
<person name="Baum T."/>
<person name="Everitt A."/>
<person name="Laufman O."/>
<person name="Tassetto M."/>
<person name="Shales M."/>
<person name="Stevenson E."/>
<person name="Iglesias G.N."/>
<person name="Shokat L."/>
<person name="Tripathi S."/>
<person name="Balasubramaniam V."/>
<person name="Webb L.G."/>
<person name="Aguirre S."/>
<person name="Willsey A.J."/>
<person name="Garcia-Sastre A."/>
<person name="Pollard K.S."/>
<person name="Cherry S."/>
<person name="Gamarnik A.V."/>
<person name="Marazzi I."/>
<person name="Taunton J."/>
<person name="Fernandez-Sesma A."/>
<person name="Bellen H.J."/>
<person name="Andino R."/>
<person name="Krogan N.J."/>
</authorList>
<dbReference type="PubMed" id="30550790"/>
<dbReference type="DOI" id="10.1016/j.cell.2018.11.028"/>
</citation>
<scope>INTERACTION WITH ZIKA VIRUS FRENCH POLYNESIA 10087PF/2013 NS5; DENGUE VIRUS DENV2 16681 NS5 AND DENGUE VIRUS DENV4 DOMINICA/814669/1981 NS5</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="657" last="663">
<title>HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.</title>
<authorList>
<person name="Howell V.M."/>
<person name="Haven C.J."/>
<person name="Kahnoski K."/>
<person name="Khoo S.K."/>
<person name="Petillo D."/>
<person name="Chen J."/>
<person name="Fleuren G.J."/>
<person name="Robinson B.G."/>
<person name="Delbridge L.W."/>
<person name="Philips J."/>
<person name="Nelson A.E."/>
<person name="Krause U."/>
<person name="Hammje K."/>
<person name="Dralle H."/>
<person name="Hoang-Vu C."/>
<person name="Gimm O."/>
<person name="Marsh D.J."/>
<person name="Morreau H."/>
<person name="Teh B.T."/>
</authorList>
<dbReference type="PubMed" id="12960210"/>
<dbReference type="DOI" id="10.1136/jmg.40.9.657"/>
</citation>
<scope>VARIANT HRPT1 PRO-64</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="878" last="883">
<title>A Novel IVS2-1G&gt;A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome.</title>
<authorList>
<person name="Moon S.D."/>
<person name="Park J.H."/>
<person name="Kim E.M."/>
<person name="Kim J.H."/>
<person name="Han J.H."/>
<person name="Yoo S.J."/>
<person name="Yoon K.H."/>
<person name="Kang M.I."/>
<person name="Lee K.W."/>
<person name="Son H.Y."/>
<person name="Kang S.K."/>
<person name="Oh S.J."/>
<person name="Kim K.M."/>
<person name="Yoon S.J."/>
<person name="Park J.G."/>
<person name="Kim I.J."/>
<person name="Kang H.C."/>
<person name="Hong S.W."/>
<person name="Kim K.R."/>
<person name="Cha B.Y."/>
</authorList>
<dbReference type="PubMed" id="15613436"/>
<dbReference type="DOI" id="10.1210/jc.2004-0991"/>
</citation>
<scope>VARIANT HRPT2 5-LEU--GLN-10 DEL</scope>
<scope>INVOLVEMENT IN HRPT2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Clin. Endocrinol. (Oxf.)" volume="64" first="299" last="306">
<title>Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.</title>
<authorList>
<person name="Bradley K.J."/>
<person name="Cavaco B.M."/>
<person name="Bowl M.R."/>
<person name="Harding B."/>
<person name="Cranston T."/>
<person name="Fratter C."/>
<person name="Besser G.M."/>
<person name="Conceicao Pereira M."/>
<person name="Davie M.W."/>
<person name="Dudley N."/>
<person name="Leite V."/>
<person name="Sadler G.P."/>
<person name="Seller A."/>
<person name="Thakker R.V."/>
</authorList>
<dbReference type="PubMed" id="16487440"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2006.02460.x"/>
</citation>
<scope>VARIANT HRPT2 ASN-379</scope>
<scope>VARIANT HRPT1 PRO-95</scope>
<scope>INVOLVEMENT IN HRPT1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Endocr. Relat. Cancer" volume="13" first="509" last="523">
<title>Loss of parafibromin expression in a subset of parathyroid adenomas.</title>
<authorList>
<person name="Juhlin C."/>
<person name="Larsson C."/>
<person name="Yakoleva T."/>
<person name="Leibiger I."/>
<person name="Leibiger B."/>
<person name="Alimov A."/>
<person name="Weber G."/>
<person name="Hoog A."/>
<person name="Villablanca A."/>
</authorList>
<dbReference type="PubMed" id="16728578"/>
<dbReference type="DOI" id="10.1677/erc.1.01058"/>
</citation>
<scope>VARIANT SER-272</scope>
<scope>ASSOCIATION WITH PARATHYROID ADENOMA</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Clin. Endocrinol. (Oxf.)" volume="67" first="370" last="376">
<title>Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.</title>
<authorList>
<person name="Haven C.J."/>
<person name="van Puijenbroek M."/>
<person name="Tan M.H."/>
<person name="Teh B.T."/>
<person name="Fleuren G.J."/>
<person name="van Wezel T."/>
<person name="Morreau H."/>
</authorList>
<dbReference type="PubMed" id="17555500"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2007.02894.x"/>
</citation>
<scope>VARIANT PHE-59</scope>
<scope>ASSOCIATION WITH PARATHYROID CARCINOMA</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Endocr. Relat. Cancer" volume="14" first="493" last="499">
<title>Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.</title>
<authorList>
<person name="Cetani F."/>
<person name="Pardi E."/>
<person name="Ambrogini E."/>
<person name="Viacava P."/>
<person name="Borsari S."/>
<person name="Lemmi M."/>
<person name="Cianferotti L."/>
<person name="Miccoli P."/>
<person name="Pinchera A."/>
<person name="Arnold A."/>
<person name="Marcocci C."/>
</authorList>
<dbReference type="PubMed" id="17639062"/>
<dbReference type="DOI" id="10.1677/erc-06-0092"/>
</citation>
<scope>VARIANTS SER-2 AND PRO-91</scope>
<scope>ASSOCIATION WITH PARATHYROID ADENOMA</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="3440" last="3449">
<title>Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene.</title>
<authorList>
<person name="Zhao J."/>
<person name="Yart A."/>
<person name="Frigerio S."/>
<person name="Perren A."/>
<person name="Schraml P."/>
<person name="Weisstanner C."/>
<person name="Stallmach T."/>
<person name="Krek W."/>
<person name="Moch H."/>
</authorList>
<dbReference type="PubMed" id="17130827"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210131"/>
</citation>
<scope>VARIANTS GLN-34 AND LYS-292</scope>
<scope>CHARACTERIZATION OF VARIANT GLN-34</scope>
<scope>ASSOCIATION WITH RENAL TUMORS</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Endocr. Relat. Cancer" volume="15" first="1115" last="1126">
<title>Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.</title>
<authorList>
<person name="Masi G."/>
<person name="Barzon L."/>
<person name="Iacobone M."/>
<person name="Viel G."/>
<person name="Porzionato A."/>
<person name="Macchi V."/>
<person name="De Caro R."/>
<person name="Favia G."/>
<person name="Palu G."/>
</authorList>
<dbReference type="PubMed" id="18755853"/>
<dbReference type="DOI" id="10.1677/erc-08-0066"/>
</citation>
<scope>VARIANT HRPT1 PRO-63</scope>
<scope>INVOLVEMENT IN HRPT1</scope>
</reference>
<comment type="function">
<text evidence="13 15 16 18 20 26 27 28 29 30">Tumor suppressor probably involved in transcriptional and post-transcriptional control pathways. May be involved in cell cycle progression through the regulation of cyclin D1/PRAD1 expression. Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1; it promotes leukemogenesis through association with KMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9 and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Connects PAF1C with the cleavage and polyadenylation specificity factor (CPSF) complex and the cleavage stimulation factor (CSTF) complex, and with Wnt signaling. Involved in polyadenylation of mRNA precursors.</text>
</comment>
<comment type="subunit">
<text evidence="9 15 16 18 21 26 27 28 29 31">Component of the PAF1 complex, which consists of CDC73, PAF1, LEO1, CTR9, RTF1 and WDR61 (PubMed:19952111, PubMed:20178742). The PAF1 complex interacts with PHF5A. Within the PAF1 complex interacts directly with PHF5A (By similarity). Interacts with POLR2A, CPSF1, CPSF4, CSTF2, KMT2A/MLL1 and CTNNB1 (PubMed:15632063, PubMed:15923622, PubMed:16630820, PubMed:19136632, PubMed:20541477). Interacts with a Set1-like complex that has histone methyltransferase activity and methylates histone H3 (PubMed:15632063). Found in a complex with BCL9L or BCL9, CDC73, CTNNB1 and PYGO1 indicative for the participation in a nuclear Wnt signaling complex (PubMed:17113272). Interacts with PTPN11 (PubMed:26742426). Interacts with SETD5 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="32">(Microbial infection) The PAF1 complex interacts with Zika virus French Polynesia 10087PF/2013 non-structural protein 5/NS5 (PubMed:30550790). The interaction with viral NS5 proteins may reduce the antiviral immune response by inhibiting the recruitment of the PAF1 complex to interferon-stimulated genes, thus preventing their transcription (PubMed:30550790).</text>
</comment>
<comment type="subunit">
<text evidence="32">(Microbial infection) The PAF1 complex interacts with Dengue virus DENV2 16681 non-structural protein 5/NS5 (PubMed:30550790). The PAF1 complex interacts with Dengue virus DENV4 Dominica/814669/1981 non-structural protein 5/NS5 (PubMed:30550790). The interaction with viral NS5 proteins may reduce the antiviral immune response by inhibiting the recruitment of the PAF1 complex to interferon-stimulated genes, thus preventing their transcription (PubMed:30550790).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-3905054">
<id>P13196</id>
<label>ALAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-533127">
<id>O00512</id>
<label>BCL9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-739624">
<id>Q8NHQ1</id>
<label>CEP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-725860">
<id>O95639</id>
<label>CPSF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-711360">
<id>P33240</id>
<label>CSTF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-1019583">
<id>Q6PD62</id>
<label>CTR9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-744366">
<id>Q96KQ7</id>
<label>EHMT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-5661036">
<id>A1L4K1</id>
<label>FSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-618309">
<id>Q08379</id>
<label>GOLGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-5916454">
<id>A6NEM1</id>
<label>GOLGA6L9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-7116203">
<id>O75031</id>
<label>HSF2BP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-749265">
<id>Q8N6L0</id>
<label>KASH5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-591370">
<id>Q03164</id>
<label>KMT2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-932432">
<id>Q8WVC0</id>
<label>LEO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-742948">
<id>Q5JR59</id>
<label>MTUS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-11522433">
<id>Q5JR59-3</id>
<label>MTUS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-2607770">
<id>Q8N7H5</id>
<label>PAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-79165">
<id>Q9NRD5</id>
<label>PICK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-295301">
<id>P24928</id>
<label>POLR2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-17635971">
<id>Q06124-2</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-447043">
<id>Q15276</id>
<label>RABEP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-2372238">
<id>Q5VTR2</id>
<label>RNF20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-1055239">
<id>Q92541</id>
<label>RTF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-79691">
<id>Q15047</id>
<label>SETDB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-717422">
<id>Q12800</id>
<label>TFCP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-740098">
<id>P36406</id>
<label>TRIM23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-744794">
<id>Q9BZW7</id>
<label>TSGA10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
</interactant>
<interactant intactId="EBI-4400866">
<id>Q9H9H4</id>
<label>VPS37B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 15 16">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="13">Found in adrenal and parathyroid glands, kidney and heart.</text>
</comment>
<comment type="PTM">
<text evidence="31">Phosphorylated. Dephosphorylated by PTPN11.</text>
</comment>
<comment type="disease" evidence="10 11 15 17 25">
<disease id="DI-01589">
<name>Hyperparathyroidism 1</name>
<acronym>HRPT1</acronym>
<description>An autosomal dominant disorder characterized by hypercalcemia, elevated parathyroid hormone (PTH) levels, and uniglandular or multiglandular parathyroid hyperplasia, adenomas, and carcinomas.</description>
<dbReference type="MIM" id="145000"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="10 14 17">
<disease id="DI-01780">
<name>Hyperparathyroidism 2 with jaw tumors</name>
<acronym>HRPT2</acronym>
<description>An autosomal dominant neoplasia syndrome characterized by primary hyperparathyroidism, ossifying fibroma of the maxilla and/or mandible, renal tumor, and uterine tumors. It is associated with increased risk of parathyroid cancer.</description>
<dbReference type="MIM" id="145001"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12">
<disease id="DI-02129">
<name>Parathyroid carcinoma</name>
<acronym>PRTC</acronym>
<description>These cancers characteristically result in more profound clinical manifestations of hyperparathyroidism than do parathyroid adenomas, the most frequent cause of primary hyperparathyroidism. Early en bloc resection of the primary tumor is the only curative treatment.</description>
<dbReference type="MIM" id="608266"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the CDC73 family.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH07325" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence starting in position 300.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB15608" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CDC73ID181ch1q31.html"/>
</comment>
<dbReference type="EMBL" id="AF312865">
<property type="protein sequence ID" value="AAG45339.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK026969">
<property type="protein sequence ID" value="BAB15608.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314772">
<property type="protein sequence ID" value="BAG37309.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139133">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL390863">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471067">
<property type="protein sequence ID" value="EAW91250.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007325">
<property type="protein sequence ID" value="AAH07325.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014351">
<property type="protein sequence ID" value="AAH14351.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC065037">
<property type="protein sequence ID" value="AAH65037.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1382.1"/>
<dbReference type="RefSeq" id="NP_078805.3">
<property type="nucleotide sequence ID" value="NM_024529.4"/>
</dbReference>
<dbReference type="PDB" id="5YDE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.02"/>
<property type="chains" value="A=1-111"/>
</dbReference>
<dbReference type="PDB" id="5YDF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B=1-100"/>
</dbReference>
<dbReference type="PDB" id="6TED">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="X=1-531"/>
</dbReference>
<dbReference type="PDBsum" id="5YDE"/>
<dbReference type="PDBsum" id="5YDF"/>
<dbReference type="PDBsum" id="6TED"/>
<dbReference type="SMR" id="Q6P1J9"/>
<dbReference type="BioGRID" id="122724">
<property type="interactions" value="290"/>
</dbReference>
<dbReference type="CORUM" id="Q6P1J9"/>
<dbReference type="DIP" id="DIP-37884N"/>
<dbReference type="IntAct" id="Q6P1J9">
<property type="interactions" value="240"/>
</dbReference>
<dbReference type="MINT" id="Q6P1J9"/>
<dbReference type="STRING" id="9606.ENSP00000356405"/>
<dbReference type="iPTMnet" id="Q6P1J9"/>
<dbReference type="PhosphoSitePlus" id="Q6P1J9"/>
<dbReference type="BioMuta" id="CDC73"/>
<dbReference type="DMDM" id="74749063"/>
<dbReference type="EPD" id="Q6P1J9"/>
<dbReference type="jPOST" id="Q6P1J9"/>
<dbReference type="MassIVE" id="Q6P1J9"/>
<dbReference type="MaxQB" id="Q6P1J9"/>
<dbReference type="PaxDb" id="Q6P1J9"/>
<dbReference type="PeptideAtlas" id="Q6P1J9"/>
<dbReference type="PRIDE" id="Q6P1J9"/>
<dbReference type="ProteomicsDB" id="66834"/>
<dbReference type="ABCD" id="Q6P1J9">
<property type="antibodies" value="3 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4286">
<property type="antibodies" value="253 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="79577"/>
<dbReference type="Ensembl" id="ENST00000367435">
<property type="protein sequence ID" value="ENSP00000356405"/>
<property type="gene ID" value="ENSG00000134371"/>
</dbReference>
<dbReference type="GeneID" id="79577"/>
<dbReference type="KEGG" id="hsa:79577"/>
<dbReference type="UCSC" id="uc001gtb.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="79577"/>
<dbReference type="DisGeNET" id="79577"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134371.9"/>
<dbReference type="GeneCards" id="CDC73"/>
<dbReference type="GeneReviews" id="CDC73"/>
<dbReference type="HGNC" id="HGNC:16783">
<property type="gene designation" value="CDC73"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000134371">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="CDC73"/>
<dbReference type="MIM" id="145000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="145001">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607393">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608266">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6P1J9"/>
<dbReference type="OpenTargets" id="ENSG00000134371"/>
<dbReference type="Orphanet" id="99879">
<property type="disease" value="Familial isolated hyperparathyroidism"/>
</dbReference>
<dbReference type="Orphanet" id="99880">
<property type="disease" value="Hyperparathyroidism-jaw tumor syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="143">
<property type="disease" value="Parathyroid carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29464"/>
<dbReference type="eggNOG" id="KOG3786">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000001114"/>
<dbReference type="HOGENOM" id="CLU_025849_0_1_1"/>
<dbReference type="InParanoid" id="Q6P1J9"/>
<dbReference type="KO" id="K15175"/>
<dbReference type="OMA" id="NVARWAV"/>
<dbReference type="OrthoDB" id="720340at2759"/>
<dbReference type="PhylomeDB" id="Q6P1J9"/>
<dbReference type="TreeFam" id="TF313016"/>
<dbReference type="PathwayCommons" id="Q6P1J9"/>
<dbReference type="Reactome" id="R-HSA-112382">
<property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5632684">
<property type="pathway name" value="Hedgehog 'on' state"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75955">
<property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866654">
<property type="pathway name" value="E3 ubiquitin ligases ubiquitinate target proteins"/>
</dbReference>
<dbReference type="SignaLink" id="Q6P1J9"/>
<dbReference type="SIGNOR" id="Q6P1J9"/>
<dbReference type="BioGRID-ORCS" id="79577">
<property type="hits" value="731 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CDC73">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CDC73"/>
<dbReference type="GenomeRNAi" id="79577"/>
<dbReference type="Pharos" id="Q6P1J9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q6P1J9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q6P1J9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134371">
<property type="expression patterns" value="Expressed in calcaneal tendon and 219 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q6P1J9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q6P1J9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016593">
<property type="term" value="C:Cdc73/Paf1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000993">
<property type="term" value="F:RNA polymerase II complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001711">
<property type="term" value="P:endodermal cell fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033523">
<property type="term" value="P:histone H2B ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010390">
<property type="term" value="P:histone monoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006378">
<property type="term" value="P:mRNA polyadenylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050680">
<property type="term" value="P:negative regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045638">
<property type="term" value="P:negative regulation of myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902808">
<property type="term" value="P:positive regulation of cell cycle G1/S phase transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031442">
<property type="term" value="P:positive regulation of mRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032968">
<property type="term" value="P:positive regulation of transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034402">
<property type="term" value="P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019827">
<property type="term" value="P:stem cell population maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.11990">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007852">
<property type="entry name" value="Cdc73/Parafibromin"/>
</dbReference>
<dbReference type="InterPro" id="IPR031336">
<property type="entry name" value="CDC73_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR038103">
<property type="entry name" value="CDC73_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR032041">
<property type="entry name" value="Cdc73_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12466">
<property type="entry name" value="PTHR12466"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05179">
<property type="entry name" value="CDC73_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16050">
<property type="entry name" value="CDC73_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="4 5 33">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Parafibromin" id="PRO_0000191803">
<location>
<begin position="2"/>
<end position="531"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with POLR2A and PAF1">
<location>
<begin position="200"/>
<end position="531"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CTNNB1" evidence="18">
<location>
<begin position="200"/>
<end position="250"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="125"/>
<end position="139"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ile">
<location>
<begin position="361"/>
<end position="364"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="4 5 33">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 6">
<location>
<position position="212"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="198"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 8">
<location>
<position position="301"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="308"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="Found in parathyroid adenoma samples; somatic mutation; parathyroid adenoma samples are from a patient with isolated hyperparathyroidism who also carries germline mutation P-91." id="VAR_064927" evidence="24">
<original>A</original>
<variation>S</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In HRPT2; unknown pathological significance; found as somatic mutation in a parathyroid carcinoma sample from a patient who also carries a germline mutation causing a splicing defect." id="VAR_064928" evidence="14">
<location>
<begin position="5"/>
<end position="10"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a clear cell renal carcinoma sample; somatic mutation; unlike wild-type protein the mutant is defective in suppressing CCND1 expression in vivo." id="VAR_064929" evidence="22">
<original>K</original>
<variation>Q</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a parathyroid carcinoma sample; somatic mutation." id="VAR_064930" evidence="23">
<original>S</original>
<variation>F</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In HRPT1; unknown pathological significance; dbSNP:rs1060500015." id="VAR_064931" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In HRPT1; does not affect interaction with the Pfa1 complex; dbSNP:rs121434264." id="VAR_024082" evidence="10 11 15">
<original>L</original>
<variation>P</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with isolated hyperparathyroidism and parathyroid adenomas." id="VAR_064932" evidence="24">
<original>R</original>
<variation>P</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In HRPT1; unknown pathological significance; found as somatic mutation in a parathyroid adenoma sample from a patient who also carries a germline frameshift mutation." id="VAR_064933" evidence="17">
<original>L</original>
<variation>P</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a parathyroid adenoma sample; dbSNP:rs752383339." id="VAR_064934" evidence="19">
<original>N</original>
<variation>S</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a Wilms tumor sample; somatic mutation." id="VAR_064935" evidence="22">
<original>R</original>
<variation>K</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In HRPT2; dbSNP:rs971586985." id="VAR_064936" evidence="17">
<original>D</original>
<variation>N</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35590728." id="VAR_031825">
<original>L</original>
<variation>P</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH14351." ref="5" evidence="34">
<original>Q</original>
<variation>G</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAB15608." ref="2" evidence="34">
<original>AIKA</original>
<variation>CNQT</variation>
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAB15608." ref="2" evidence="34">
<original>I</original>
<variation>K</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="4"/>
<end position="14"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="24"/>
<end position="27"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="57"/>
<end position="65"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="71"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="88"/>
<end position="98"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5YDE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8JZM7"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12434154"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12960210"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14585940"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15580289"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15613436"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15632063"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15923622"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16487440"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16630820"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16728578"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16989776"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17113272"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17130827"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17555500"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17639062"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18755853"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19136632"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19952111"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20178742"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20541477"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21329879"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26742426"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30550790"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="531" mass="60577" checksum="894A7448DBC0E793" modified="2004-07-05" version="1">MADVLSVLRQYNIQKKEIVVKGDEVIFGEFSWPKNVKTNYVVWGTGKEGQPREYYTLDSILFLLNNVHLSHPVYVRRAATENIPVVRRPDRKDLLGYLNGEASTSASIDRSAPLEIGLQRSTQVKRAADEVLAEAKKPRIEDEECVRLDKERLAARLEGHKEGIVQTEQIRSLSEAMSVEKIAAIKAKIMAKKRSTIKTDLDDDITALKQRSFVDAEVDVTRDIVSRERVWRTRTTILQSTGKNFSKNIFAILQSVKAREEGRAPEQRPAPNAAPVDPTLRTKQPIPAAYNRYDQERFKGKEETEGFKIDTMGTYHGMTLKSVTEGASARKTQTPAAQPVPRPVSQARPPPNQKKGSRTPIIIIPAATTSLITMLNAKDLLQDLKFVPSDEKKKQGCQRENETLIQRRKDQMQPGGTAISVTVPYRVVDQPLKLMPQDWDRVVAVFVQGPAWQFKGWPWLLPDGSPVDIFAKIKAFHLKYDEVRLDPNVQKWDVTVLELSYHKRHLDRPVFLRFWETLDRYMVKHKSHLRF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

